- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Dissertation, 2021
- Schlagwort
-
Cells
Cancer
Liver--Cancer
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (wann)
-
2021
- Urheber
- Beteiligte Personen und Organisationen
-
Werner, Jens
- DOI
-
10.5282/edoc.29245
- URN
-
urn:nbn:de:bvb:19-292455
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:51 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Xinyu
- Werner, Jens
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Entstanden
- 2021
Ähnliche Objekte (12)
The cancer stem cell in hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Acquired resistance to antiangiogenic therapies in hepatocellular carcinoma is mediated by yes‐associated protein 1 activation and transient expansion of stem‐like cancer cells
Multidisciplinary treatment of hepatocellular carcinoma
Pathogenesis of human hepatocellular carcinoma
Targeting FUBP1 in Hepatocellular Carcinoma
Progress in hepatocellular carcinoma treatment
Targeting FUBP1 in hepatocellular carcinoma
SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types
Immunophenotyping of the hepatocellular carcinoma patients
Immunoregulatory properties of cancer stem-like cells derived from carcinoma cell lines of the cervix uteri
Genetically engineering mesenchymal stem cells for targeting tumor stroma and angiogenesis in hepatocellular carcinoma
The cancer stem cell in hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Acquired resistance to antiangiogenic therapies in hepatocellular carcinoma is mediated by yes‐associated protein 1 activation and transient expansion of stem‐like cancer cells
Multidisciplinary treatment of hepatocellular carcinoma
Pathogenesis of human hepatocellular carcinoma
Targeting FUBP1 in Hepatocellular Carcinoma
Progress in hepatocellular carcinoma treatment
Targeting FUBP1 in hepatocellular carcinoma
SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types
Immunophenotyping of the hepatocellular carcinoma patients
Immunoregulatory properties of cancer stem-like cells derived from carcinoma cell lines of the cervix uteri
Genetically engineering mesenchymal stem cells for targeting tumor stroma and angiogenesis in hepatocellular carcinoma
The cancer stem cell in hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Acquired resistance to antiangiogenic therapies in hepatocellular carcinoma is mediated by yes‐associated protein 1 activation and transient expansion of stem‐like cancer cells
Multidisciplinary treatment of hepatocellular carcinoma
Pathogenesis of human hepatocellular carcinoma
Targeting FUBP1 in Hepatocellular Carcinoma
Progress in hepatocellular carcinoma treatment
Targeting FUBP1 in hepatocellular carcinoma
SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types
Immunophenotyping of the hepatocellular carcinoma patients
Immunoregulatory properties of cancer stem-like cells derived from carcinoma cell lines of the cervix uteri